Very Late Scaffold Thrombosis: Intracoronary Imaging and Histopathological and Spectroscopic Findings. - Wikidata - awgldk - TriplyDB

Very Late Scaffold Thrombosis: Intracoronary Imaging and Histopathological and Spectroscopic Findings.

Very Late Scaffold Thrombosis: Intracoronary Imaging and Histopathological and Spectroscopic Findings.

http://www.wikidata.org/entity/Q51675620

about

Bioresorbable vascular scaffolds technology: current use and future developments Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial.Intracoronary imaging of coronary atherosclerosis: validation for diagnosis, prognosis and treatment.Percutaneous Coronary Intervention: 2015 in Review.The unmet needs: How future technologies will address current limitations of bioresorbable scaffold technology.Dual antiplatelet therapy after coronary stenting.Bioresorbable Scaffolds for Coronary Stenosis: When and How Based Upon Current Studies.Bioresorbable Scaffolds for Coronary Artery Disease.Late thrombotic events after bioresorbable scaffold implantation: a systematic review and meta-analysis of randomized clinical trials.Stent thrombosis and optimal duration of dual antiplatelet therapy after coronary stenting in contemporary practice.Very late bioresorbable scaffold thrombosis and reoccurrence of dissection two years later chronic total occlusion recanalization of the left anterior descending artery.Managing the treatment of the patients with stable angina like a chess player: making moves considering the next move of atherosclerosis.The first generation ABSORB BVS scaffold; to be or not to be?Very late bioresorbable vascular scaffold thrombosis at 25 months post implantation.Bioabsorbable Scaffolds: Can the Problems of Dissolution Be Overcome?BRS implantation in long lesions requiring device overlapping: myth or reality?Bioresorbable stents: quo vantis?Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary.BRS implantation in long lesions requiring device overlapping: myth or reality?New insight to estimate under-expansion after stent implantation on bifurcation lesions using optical coherence tomography.Imaging assessment of bioresorbable vascular scaffolds.Magmaris: a new generation metallic sirolimus-eluting fully bioresorbable scaffold: present status and future perspectives.One-year clinical and computed tomography follow-up after implantation of bioresorbable vascular scaffolds in patients with coronary chronic total occlusions.Preliminary Report of Clinical Outcomes After Single Crossover Bioresorbable Scaffold Implantation Without Routine Side Branch Strut Dilation.Scaffold thrombosis following implantation of the ABSORB BVS in routine clinical practice: Insight into possible mechanisms from optical coherence tomography.Bioresorbable vascular scaffolds: From patient selection to optimal scaffold implantation; tips and tricks to minimize device failure.Bioresorbable scaffold -fourth revolution or failed revolution: Is low scaffold strut thickness the wrong target?Multianalysis with optical coherence tomography and vasomotion in everolimus-eluting stents and everolimus-eluting biovascular scaffolds: the MOVES trial.2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.Impact of PSP Technique on Clinical Outcomes Following Bioresorbable Scaffolds Implantation.The mechanisms of late scaffold thrombosis.Use of a bioresorbable novolimus eluting vascular scaffold fails a hybrid PCI strategy with drug eluting stent.Intraluminal bioresorbable vascular scaffold dismantling with aneurysm formation leading to very late thrombosis.Bioresorbable Coronary Scaffolds: Deployment Tips and Tricks and the Future of the Technology.Cardiovascular Disease in Patients with End-Stage Renal Disease on Hemodialysis.Practical issues in clinical scenarios involving CKD patients requiring antithrombotic therapy in light of the 2017 ESC guideline recommendations 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS Undiscovered pathology of transient scaffolding t1remains a driver of failures in clinical trials

P2860

Q26741147-491D005A-7E56-4A4B-AFF9-2C77FAA900EA Q37285036-82618813-E19F-4260-9C4C-79FE669D5238 Q38665986-63ED44A0-7358-4EB8-BEFC-F528014C14AD Q38728869-8573F328-75C1-4B0B-B4B1-69478DE17BA0 Q38802127-C8C9AED4-DD3D-45CC-B9B8-63C5A03141FC Q38866836-F8504168-1CAB-43F6-BDB9-D2F1579CC49E Q38904242-76623449-B6D1-4F98-A023-D940189098AB Q39097196-13E99594-FD55-4B0A-BC31-A25EF3E6A840 Q39254915-B16712C8-EDB3-42B9-B398-F382A47A5A88 Q41607661-B54121B9-8B97-41F9-BCB5-C33C478862DF Q41608297-7138B141-9656-435C-BC8E-F651944F45D0 Q42328756-F911FA8F-FB99-4114-8CC6-0917527243BC Q42334034-996F3C40-1469-43CB-8783-4F7CEAE19FB7 Q42735069-3CF15224-37A2-4D51-8140-7E33F2D76673 Q45061142-724FBCAB-38F2-48AA-BE0F-D5B14C4FC7E3 Q47096601-4F1B4605-DE9E-4A88-A1D9-F2CB3A09C82C Q47136269-64B60584-5553-4C31-9AEA-E4CA6B79FCF5 Q47579904-FBDF1A86-74C5-446A-9429-ABE983BF1340 Q47687022-8ADD4591-1605-44ED-94D8-75BCBAF46828 Q47809588-6C15F489-C26A-4828-88A8-DBF989D24D2E Q47854554-A889C5CF-9925-4E3B-BF97-83B64DB0A937 Q47954131-A32DBCEE-39FC-4F76-A61F-540688CC6BFF Q48130911-E01FE7FA-3C2E-4C5D-AED5-BBD516E0A4AC Q48224209-B366658E-8F6D-4D8F-B57A-95A98314E2CE Q48247960-448C9E92-9F62-4F39-843E-D13435718A04 Q48949945-4BFBD7A9-7CEF-4AF8-80BF-24A98767284A Q49646912-043BD3E4-72E9-40D7-AA41-F271CB64CC60 Q49985062-846D47AA-5F19-45E2-B0CB-44ACB700263D Q50089557-552D6158-233D-4AF4-A274-7C2904424AFD Q50131888-D86D1DD7-CEF7-470C-A950-A196AC3A948B Q50199689-FE44E316-8C8D-428F-A78D-9DA6D5B5D898 Q50663676-0D9A5A38-E9FB-456A-AF3E-A0C21292900F Q51022612-14090910-4064-4899-8DC4-29C873274433 Q52603571-02C892DA-E91A-4DEE-96CB-A4ADC6898371 Q54973184-0AB22C63-288F-4938-94A6-2E041560D762 Q57154436-F6E0DCE2-A8D7-46D3-A6DF-EE3C4B3154A1 Q57621041-35E79E1B-582E-4F39-9EE4-9247E1A9B6AE Q58551417-2E0FB609-216B-4C8B-9634-FCA9B9F8C767

P2860

Very Late Scaffold Thrombosis: Intracoronary Imaging and Histopathological and Spectroscopic Findings.

http://www.wikidata.org/entity/Q51675620

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Very Late Scaffold Thrombosis: ...... al and Spectroscopic Findings.

@en

Very Late Scaffold Thrombosis: ...... al and Spectroscopic Findings.

@nl

type

label

Very Late Scaffold Thrombosis: ...... al and Spectroscopic Findings.

@en

Very Late Scaffold Thrombosis: ...... al and Spectroscopic Findings.

@nl

prefLabel

Very Late Scaffold Thrombosis: ...... al and Spectroscopic Findings.

@en

Very Late Scaffold Thrombosis: ...... al and Spectroscopic Findings.

@nl

P1433

Q51675620-4D829CB3-45F9-4F1E-AC00-C56D0DE4B2EC

P1476

Q51675620-B295C097-7AAD-4105-8A03-5D03162A821B

P2093

Q51675620-02EC11BC-E083-409B-ACA3-CD78CF86C0EC

Q51675620-075F9504-05AF-42C7-A46E-6303FC32E9A0

Q51675620-14C8DC10-7883-4960-B12C-FBD8A0A1AABE

Q51675620-193651C4-899D-4977-A6DF-C4FA2F3D15B4

Q51675620-3D6D6AB0-2348-4513-9442-FC2AA2E7D587

Q51675620-474645B9-7A97-4FBD-B6AD-1EF42AA19A41

Q51675620-6234E1B0-E735-4E8D-90CE-E659A4726033

Q51675620-6CEF041E-B1CC-4CA2-9FAB-174F043D816C

Q51675620-8064B90B-C03F-45D3-AD03-56EF7B3B76D3

Q51675620-8C81E933-2264-4715-9C64-5AEF2BD8AB7A

P304

Q51675620-A07DED59-594C-4E6B-94E1-7713A8BC2179

P31

Q51675620-959DF299-6721-46BA-871A-862F3903C726

P356

Q51675620-1EFBAF06-FFE1-4204-9393-7ED2F7A63F47

P407

Q51675620-8503EA95-AF0F-45E2-BFF8-5438F456DBFB

P433

Q51675620-E4C31996-154C-4C73-8564-103BC8E762E4

P478

Q51675620-93B1C2F8-E2BF-4431-9560-6754D8157F7D

P50

Q51675620-2B910CA7-C244-4D0D-B823-25477ABBABDA

Q51675620-40D0CBDF-084B-4DA9-9CA5-29CA62A2B5F1

Q51675620-B1B3A9D0-8FCA-492A-A9D9-7E0C4BA12859

P577

Q51675620-EA8AE56F-90B8-4106-88AC-129ED061D0FC

P5875

Q51675620-9722CD5F-516D-496E-B72B-AAE61AAD7C73

P698

Q51675620-A268AA52-78C4-48CF-9BF4-EF86FAA375E0

P921

Q51675620-8C612AC6-4F74-4262-A8B0-0E3AABDF8642

P356

J.JACC.2015.08.853

P1433

Journal of the American College of Cardiology

P1476

Very Late Scaffold Thrombosis: ...... al and Spectroscopic Findings.

@en

P2093

Crochan J O'Sullivan

http://www.w3.org/2001/XMLSchema#string

Franz R Eberli

http://www.w3.org/2001/XMLSchema#string

Kyohei Yamaji

http://www.w3.org/2001/XMLSchema#string

Manel Sabaté

http://www.w3.org/2001/XMLSchema#string

Masanori Taniwaki

http://www.w3.org/2001/XMLSchema#string

Michael Joner

http://www.w3.org/2001/XMLSchema#string

Salvatore Brugaletta

http://www.w3.org/2001/XMLSchema#string

Shuji Otsuki

http://www.w3.org/2001/XMLSchema#string

Tobias Koppara

http://www.w3.org/2001/XMLSchema#string

Xavier Freixa

http://www.w3.org/2001/XMLSchema#string

P304

1901-1914

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACC.2015.08.853

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P50

Patrick W Serruys

Stephan Windecker

P577

2015-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

284007195

http://www.w3.org/2001/XMLSchema#string

P698

26493663

http://www.w3.org/2001/XMLSchema#string

P921